Nonalcoholic fatty liver disease (NAFLD) is a growing worldwide epidemic and an important
risk factor for the development of insulin resistance, type 2 diabetes, nonalcoholic …

Liver disease, involving a wide range of liver pathologies from fatty liver, hepatitis, and
fibrosis to cirrhosis and hepatocellular carcinoma, is a serious health problem worldwide. In …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world. Resveratrol is a polyphenolic compound with antioxidant capacity that shows …

Resveratrol (3, 4′, 5-trihydroxy-trans-stilbene, RSV), a nutraceutical, has recently attracted
lots of attention because of its outstanding pharmacological potential. The effects of RSV on …

Background Stilbenes are a group of naturally occurring phenolic compounds. These
compounds are synthetized by plants in response of biotic or abiotic stress situations. The …

Non-alcoholic fatty liver disease (NAFLD) is usually associated with insulin resistance,
central obesity, reduced glucose tolerance, type 2 diabetes mellitus and …

Nonalcoholic fatty liver disease (NAFLD) defines fat accumulation in the liver, and it is
commonly associated with metabolic syndromes like diabetes and obesity. Progressive …

The healthy effects of plant polyphenols, some of which characterize the so-called
Mediterranean diet, have been shown to arise from epigenetic and biological modifications …

Hepatocellular carcinoma (HCC) is an increasing burden on global public health and is
associated with enhanced lipogenesis, fatty acid uptake, and lipid metabolic …

Objective: There is a promising perspective regarding the potential effect of resveratrol in
preventing and treating metabolic disturbances similar to that of calorie restriction. The aim …